Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. WI BioHistory (TM)
Career
Job Search Post a Job Submit Resume Destination WI
News/Events
Local WI News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Local Support National Resources
Education
K-12 Higher Ed BioEd Reading
About
Board Advertising Feedback Home
 
News
 Local WI News
 Submit News Release
 Calendar
 Submit Event
 CEO Reading
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: Children Affected by AIDS Foundation
Advertising
 
Jobs
 

ATC clean room constructors...validation guaranteed!


News

Local News

Submit News Release


Search Articles: 

  • Medtronic first quarter revenue up 19 percent to $3.706 billion  Medtronic announced financial results for its first quarter of fiscal year 2009, which ended July 25, 2008. Medtronic recorded first quarter revenue of $3.706 billion, a 19 percent increase over the $3.127 billion reported in the first quarter of fiscal year 2008.
    Medtronic, Inc. August 19, 2008  
  • Corn farmers who use Monsanto advanced technology eligible for lower insurance premiums  Farmers in 11 states who plant a majority of their corn acres using hybrid seeds featuring YieldGard Plus with Roundup Ready Corn 2, YieldGard VT Triple and YieldGard VT Triple PRO technology from Monsanto Company will have an opportunity to lower their crop insurance premiums in 2009.
    Monsanto Company August 19, 2008  
  • Patient side point-of-care testing enables quicker treatment decisions  Patient side point-of-care testing - where diagnostic testing is conducted at or near the site of the patient - enables doctors to make decisions on patients presenting with chest pain up to 20 minutes faster than those whose lab tests are evaluated by a standard lab.
    Abbott August 19, 2008  
  • BMS and PDL BioPharma enter alliance to develop novel treatment for multiple myeloma  Bristol-Myers Squibb Company and PDL BioPharma announced an agreement for the global development and commercialization of PDL BioPharma's anti-CS1 antibody, elotuzumab, previously known as HuLuc63, currently in Phase I development for multiple myeloma.
    Bristol-Myers Squibb Company August 19, 2008  
  • Abbott and AstraZeneca expand relationship to include co-promotion of CRESTOR(R)  Abbott and AstraZeneca announced that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR(R) (rosuvastatin calcium), a medication used along with diet to reduce high cholesterol.
    Abbott August 14, 2008  
  • Pfizer says vacation with your dog before the summer ends  With canine motion sickness the leading reason pet owners are not able to take their dogs on day trips or vacation, Pfizer is encouraging more people to talk with their veterinarians about managing travel with their dog before the summer ends.
    Pfizer Inc. August 14, 2008  
  • Northfield Laboratories reports fiscal 2008 fourth quarter and year-end financial results  Northfield Laboratories announced that it has filed its Annual Report on Form 10K, letter from the Chairman, and final Proxy Statement with the Securities Exchange Commission.
    Northfield Laboratories Inc. August 14, 2008  
  • NeoPharm announces second quarter 2008 financial results  NeoPharm announced its second quarter 2008 financial results. For the second quarter ended June 30, 2008, NeoPharm reported a net loss of $2.1 million, or ($0.07) per basic and diluted share, as compared to a net loss of $3.6 million, or ($0.13) per share, for the same period last year.
    NeoPharm, Inc. August 14, 2008  
  • Genentech rejects takeover bid from Roche  Roche is expected to increase its offer for the biotechnology company Genentech now that an initial $43.7 billion bid has been rejected, analysts said. Genentech said that a special committee of directors had found that Roche's offer "substantially undervalues the company."
    The New York Times August 13, 2008  Andrew Pollack
  • Bayer’s annual report receives international praise  Praise all around for Bayer's Annual Report 2007: It received gold, silver, bronze and honors twice each in the recently concluded Annual Report Competition (ARC).
    Bayer August 12, 2008  

   (next 10 articles)

Search Articles: 


Submit News Release

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page

© 2008 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

WisconsinLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of Wisconsin.